Carlton Hofferkamp & Jenks Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
11,335
-239
-2% -$28K 0.47% 50
2026
Q1
$1.28M Sell
11,574
-16
-0.1% -$1.85K 0.43% 53
2025
Q4
$1.22M Sell
11,590
-30
-0.3% -$2.82K 0.41% 55
2025
Q3
$1.02M Sell
11,620
-338
-3% -$27.8K 0.34% 61
2025
Q2
$978K Sell
11,958
-392
-3% -$31.2K 0.35% 62
2025
Q1
$944K Sell
12,350
-785
-6% -$73.3K 0.39% 54
2024
Q4
$1.18M Sell
13,135
-57
-0.4% -$5.88K 0.43% 51
2024
Q3
$1.34M Sell
13,192
-95
-0.7% -$11.3K 0.51% 45
2024
Q2
$1.53M Sell
13,287
-45
-0.3% -$5.8K 0.6% 41
2024
Q1
$1.74M Sell
13,332
-574
-4% -$70.8K 0.73% 33
2023
Q4
$1.65M Buy
13,906
+57
+0.4% +$5.92K 0.69% 35
2023
Q3
$1.44M Buy
13,849
+100
+0.7% +$10.8K 0.67% 38
2023
Q2
$1.44M Sell
13,749
-166
-1% -$18.8K 0.64% 39
2023
Q1
$1.64M Sell
13,915
-290
-2% -$31.3K 0.75% 33
2022
Q4
$1.5M Sell
14,205
-234
-2% -$23.9K 0.66% 38
2022
Q3
$1.38M Sell
14,439
-268
-2% -$23.9K 0.65% 43
2022
Q2
$1.36M Buy
14,707
+265
+2% +$23.5K 0.63% 45
2022
Q1
$1.27M Buy
14,442
+50
+0.3% +$3.94K 0.52% 53
2021
Q4
$1.14M Buy
14,392
+175
+1% +$13.9K 0.48% 55
2021
Q3
$1.18M Buy
14,217
+680
+5% +$51.7K 0.47% 57
2021
Q2
$1.06M Buy
13,537
+143
+1% +$10.6K 0.45% 61
2021
Q1
$989K Buy
13,394
+2,382
+22% +$176K 0.44% 65
2020
Q4
$874K Buy
11,012
+15
+0.1% +$1.15K 0.43% 62
2020
Q3
$851K Buy
10,997
+425
+4% +$33.3K 0.45% 59
2020
Q2
$800K Buy
10,572
+3,086
+41% +$232K 0.46% 58
2020
Q1
$577K Buy
7,486
+3,321
+80% +$261K 0.35% 68
2019
Q4
$342K Sell
4,165
-1,949
-32% -$160K 0.19% 84
2019
Q3
$489K Hold
6,114
0.3% 69
2019
Q2
$478K Hold
6,114
0.29% 71
2019
Q1
$485K Buy
6,114
+2,013
+49% +$151K 0.3% 66
2018
Q4
$298K Sell
4,101
-110
-3% -$7.76K 0.21% 75
2018
Q3
$285K Buy
4,211
+184
+5% +$11.7K 0.17% 79
2018
Q2
$233K Buy
4,027
+29
+0.7% +$1.64K 0.15% 82
2018
Q1
$210K Sell
3,998
-3,092
-44% -$167K 0.14% 83
2017
Q4
$380K Buy
7,090
+189
+3% +$10.5K 0.24% 76
2017
Q3
$421K Buy
6,901
+2,510
+57% +$152K 0.27% 71
2017
Q2
$268K Buy
+4,391
New +$267K 0.18% 79
2016
Q3
Sell
-30,979
Closed -$1.7M 81
2016
Q2
$1.7M Buy
30,979
+68
+0.2% +$3.62K 1.34% 20
2016
Q1
$1.56M Sell
30,911
-47
-0.2% -$2.3K 1.27% 23
2015
Q4
$1.55M Buy
30,958
+3,814
+14% +$192K 1.33% 22
2015
Q3
$1.28M Buy
27,144
+20,463
+306% +$1.09M 1.24% 31
2015
Q2
$367K Buy
6,681
+1,703
+34% +$95.5K 0.34% 57
2015
Q1
$273K Buy
+4,978
New +$282K 0.27% 58
2014
Q2
Sell
-15,285
Closed -$827K 47
2014
Q1
$827K Sell
15,285
-14,890
-49% -$771K 1.07% 33
2013
Q4
$1.44M Sell
30,175
-12,652
-30% -$578K 2.03% 14
2013
Q3
$1.95M Buy
42,827
+6,506
+18% +$297K 3.12% 7
2013
Q2
$1.61M Buy
+36,321
New +$1.62M 2.57% 11

Other funds holding MRK

Carlton Hofferkamp & Jenks Wealth Management's MRK Position: Q2 2026 in Review

Carlton Hofferkamp & Jenks Wealth Management reduced its Merck (MRK) stake by 2.1% in Q2 2026, selling an estimated $28K and leaving 11,335 shares worth $1.44M. The position accounts for 0.47% of the portfolio, ranked #50.

Carlton Hofferkamp & Jenks Wealth Management first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. The position peaked at $1.95M in Q3 2013. 1,462 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Carlton Hofferkamp & Jenks Wealth Management held 11,335 shares of Merck worth $1.44M as of Q2 2026.
  • Carlton Hofferkamp & Jenks Wealth Management sold 239 Merck shares in Q2 2026, an estimated $28K.
  • Merck made up 0.47% of Carlton Hofferkamp & Jenks Wealth Management's portfolio in Q2 2026, its #50 holding.
  • Carlton Hofferkamp & Jenks Wealth Management first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
  • Carlton Hofferkamp & Jenks Wealth Management's Merck position peaked at $1.95M in Q3 2013.
  • 1,462 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Carlton Hofferkamp & Jenks Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.